Ultrasound-targeted microbubble destruction augments proteins delivery into testes

被引:28
作者
Bekeredjian, Raffi [1 ]
Kuecherer, Helmut F. [1 ]
Kroll, Richard D. [1 ]
Katus, Hugo A. [1 ]
Hardt, Stefan E. [1 ]
机构
[1] Univ Heidelberg, Dept Internal Med 3, D-69120 Heidelberg, Germany
关键词
D O I
10.1016/j.urology.2006.12.004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
OBJECTIVES Gas-filled microbubbles have become an important tool as ultrasound contrast agents. In recent years, ultrasound-targeted microbubble destruction (UTMD) has evolved into a new tool for organ-specific gene and drug delivery. Although many studies have been performed in well-perfused target organs such as the heart or kidney, no study has yet investigated the feasibility of UTMD for delivery of bioactive substances in the testis. Thus, the aim of this study was to determine whether UTMD is a feasible and safe technique to deliver a reporter protein to the testes. METHODS Different groups of rats received 2 mu g of luciferase protein at varying protocols. One group received luciferase-loaded microbubbtes infused intravenously while ultrasound was applied to the right testis. Another group received tuciferase without microbubbles but with ultrasound applied to the right testis. Protein uptake was quantified by luciferase assay. Also, to rule out UTMD-induced damage, the testes were analyzed histologically. RESULTS The testes that received ultrasound and luciferase-loaded microbubbles showed about twofold greater luciferase activity compared with testes without ultrasound or without microbubbles. No hemorrhage or microscopic damage was detected. CONCLUSIONS The results of our study have shown that UTMD is a safe and feasible technique to augment delivery of bioactive substances to the testes.
引用
收藏
页码:386 / 389
页数:4
相关论文
共 18 条
[1]
Destruction of contrast microbubbles by ultrasound - Effects on myocardial function, coronary perfusion pressure, and microvascular integrity [J].
Ay, T ;
Havaux, X ;
Van Camp, G ;
Campanelli, B ;
Gisellu, G ;
Pasquet, A ;
Denef, JF ;
Melin, JA ;
Vanoverschelde, JLJ .
CIRCULATION, 2001, 104 (04) :461-466
[2]
Therapeutic use of ultrasound targeted microbubble destruction: A review of non-cardiac applications [J].
Bekeredjian, R ;
Katus, HA ;
Kuecherer, HF .
ULTRASCHALL IN DER MEDIZIN, 2006, 27 (02) :134-140
[3]
Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction [J].
Bekeredjian, R ;
Chen, SY ;
Grayburn, PA ;
Shohet, RV .
ULTRASOUND IN MEDICINE AND BIOLOGY, 2005, 31 (05) :687-691
[4]
Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart [J].
Bekeredjian, R ;
Chen, SY ;
Frenkel, PA ;
Grayburn, PA ;
Shohet, RV .
CIRCULATION, 2003, 108 (08) :1022-1026
[5]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]
Bioeffects of myocardial contrast microbubble destruction by echocardiography [J].
Chen, SY ;
Kroll, MH ;
Shohet, RV ;
Frenkel, P ;
Mayer, SA ;
Grayburn, PA .
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2002, 19 (06) :495-500
[7]
Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles [J].
Christiansen, JP ;
French, BA ;
Klibanov, AL ;
Kaul, S ;
Lindner, JR .
ULTRASOUND IN MEDICINE AND BIOLOGY, 2003, 29 (12) :1759-1767
[8]
Correas Jean-Michel, 2006, Ultrasound Q, V22, P53
[9]
Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma [J].
Eckersley, RJ ;
Sedelaar, JPM ;
Blomley, MJK ;
Wijkstra, H ;
deSouza, NM ;
Cosgrove, DO ;
de la Rosette, JJMCH .
PROSTATE, 2002, 51 (04) :256-267
[10]
Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men [J].
Ghosn, J ;
Chaix, ML ;
Peytavin, G ;
Rey, E ;
Bresson, JL ;
Goujard, C ;
Katlama, C ;
Viard, JP ;
Tréluyer, JM ;
Rouzioux, C .
AIDS, 2004, 18 (14) :1958-1961